| ISIN | LU2807512947 |
|---|---|
| Valor Number | 140384538 |
| Bloomberg Global ID | UBMWEAU LX |
| Fund Name | UBS (Lux) Fund Solutions - UBS MSCI World ex USA UCITS ETF USD acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
| Asset Class | Asset Allocation |
| EFC Category | Equity Global Advanced Markets |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The sub-fund seeks to broadly track the performance (before costs) of the MSCI World ex USA Index (Net Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currencyhedged index variant. |
| Peculiarities |
| Current Price * | 14.58 USD | 21.11.2025 |
|---|---|---|
| Previous Price * | 14.63 USD | 20.11.2025 |
| 52 Week High * | 15.23 USD | 12.11.2025 |
| 52 Week Low * | 11.22 USD | 07.04.2025 |
| NAV * | 14.58 USD | 21.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 771,219,143 | |
| Unit/Share Assets *** | 63,174,994 | |
| Trading Information SIX | ||
| YTD Performance | - | - |
|---|---|---|
| YTD Performance (in CHF) | - | - |
| 1 month | -2.40% |
21.10.2025 - 21.11.2025
21.10.2025 21.11.2025 |
| 3 months | +0.96% |
21.08.2025 - 21.11.2025
21.08.2025 21.11.2025 |
| 6 months | +6.63% |
21.05.2025 - 21.11.2025
21.05.2025 21.11.2025 |
| 1 year | +15.02% |
24.02.2025 - 21.11.2025
24.02.2025 21.11.2025 |
| 2 years | - | - |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASML Holding NV | 1.79% | |
|---|---|---|
| AstraZeneca PLC | 1.25% | |
| Roche Holding AG | 1.23% | |
| Nestle SA | 1.17% | |
| SAP SE | 1.12% | |
| Novartis AG Registered Shares | 1.11% | |
| HSBC Holdings PLC | 1.10% | |
| Shell PLC | 0.99% | |
| Royal Bank of Canada | 0.95% | |
| Siemens AG | 0.87% | |
| Last data update | 18.11.2025 | |
| TER *** | 0.14% |
|---|---|
| TER date *** | 30.06.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.14% |
| Ongoing Charges *** | 0.14% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |